Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2437355
Max Phase: Preclinical
Molecular Formula: C27H27ClN2O6
Molecular Weight: 510.97
Molecule Type: Small molecule
Associated Items:
ID: ALA2437355
Max Phase: Preclinical
Molecular Formula: C27H27ClN2O6
Molecular Weight: 510.97
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(NC(=O)c2ccc(Cl)cc2OC(=O)[C@@H](NC(=O)OCc2ccccc2)C(C)C)cc1
Standard InChI: InChI=1S/C27H27ClN2O6/c1-17(2)24(30-27(33)35-16-18-7-5-4-6-8-18)26(32)36-23-15-19(28)9-14-22(23)25(31)29-20-10-12-21(34-3)13-11-20/h4-15,17,24H,16H2,1-3H3,(H,29,31)(H,30,33)/t24-/m0/s1
Standard InChI Key: CJBHNMMQZHPSCZ-DEOSSOPVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 510.97 | Molecular Weight (Monoisotopic): 510.1558 | AlogP: 5.46 | #Rotatable Bonds: 9 |
Polar Surface Area: 102.96 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.72 | CX Basic pKa: | CX LogP: 5.81 | CX LogD: 5.81 |
Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.29 | Np Likeness Score: -1.07 |
1. Pauk K, Zadražilová I, Imramovský A, Vinšová J, Pokorná M, Masaříková M, Cížek A, Jampílek J.. (2013) New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species., 21 (21): [PMID:24045008] [10.1016/j.bmc.2013.08.029] |
Source(1):